The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer

Histone H3 lysine 4 (H3K4) methylation is key epigenetic mark associated with active transcription and is a substrate for the KDM1A/LSD1 and KDM5B/JARID1B lysine demethylases. Increased expression of KDM1A and KDM5B is implicated in many cancer types, including prostate cancer (PCa). Both KDM1A and...

Full description

Bibliographic Details
Main Authors: Veronika M. Metzler, Simone de Brot, Daisy B. Haigh, Corinne L. Woodcock, Jennifer Lothion-Roy, Anna E. Harris, Emeli M. Nilsson, Atara Ntekim, Jenny L. Persson, Brian D. Robinson, Francesca Khani, Kristian B. Laursen, Lorraine J. Gudas, Michael S. Toss, Srinivasan Madhusudan, Emad Rakha, David M. Heery, Catrin S. Rutland, Nigel P. Mongan, Jennie N. Jeyapalan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1116424/full
_version_ 1797844275454541824
author Veronika M. Metzler
Simone de Brot
Daisy B. Haigh
Corinne L. Woodcock
Jennifer Lothion-Roy
Anna E. Harris
Emeli M. Nilsson
Atara Ntekim
Jenny L. Persson
Jenny L. Persson
Brian D. Robinson
Francesca Khani
Kristian B. Laursen
Lorraine J. Gudas
Michael S. Toss
Srinivasan Madhusudan
Emad Rakha
David M. Heery
Catrin S. Rutland
Nigel P. Mongan
Nigel P. Mongan
Jennie N. Jeyapalan
author_facet Veronika M. Metzler
Simone de Brot
Daisy B. Haigh
Corinne L. Woodcock
Jennifer Lothion-Roy
Anna E. Harris
Emeli M. Nilsson
Atara Ntekim
Jenny L. Persson
Jenny L. Persson
Brian D. Robinson
Francesca Khani
Kristian B. Laursen
Lorraine J. Gudas
Michael S. Toss
Srinivasan Madhusudan
Emad Rakha
David M. Heery
Catrin S. Rutland
Nigel P. Mongan
Nigel P. Mongan
Jennie N. Jeyapalan
author_sort Veronika M. Metzler
collection DOAJ
description Histone H3 lysine 4 (H3K4) methylation is key epigenetic mark associated with active transcription and is a substrate for the KDM1A/LSD1 and KDM5B/JARID1B lysine demethylases. Increased expression of KDM1A and KDM5B is implicated in many cancer types, including prostate cancer (PCa). Both KDM1A and KDM5B interact with AR and promote androgen regulated gene expression. For this reason, there is great interested in the development of new therapies targeting KDM1A and KDM5B, particularly in the context of castrate resistant PCa (CRPC), where conventional androgen deprivation therapies and androgen receptor signalling inhibitors are no longer effective. As there is no curative therapy for CRPC, new approaches are urgently required to suppress androgen signalling that prevent, delay or reverse progression to the castrate resistant state. While the contribution of KDM1A to PCa is well established, the exact contribution of KDM5B to PCa is less well understood. However, there is evidence that KDM5B is implicated in numerous pro-oncogenic mechanisms in many different types of cancer, including the hypoxic response, immune evasion and PI3/AKT signalling. Here we elucidate the individual and cooperative functions of KDM1A and KDM5B in PCa. We show that KDM5B mRNA and protein expression is elevated in localised and advanced PCa. We show that the KDM5 inhibitor, CPI-455, impairs androgen regulated transcription and alternative splicing. Consistent with the established role of KDM1A and KDM5B as AR coregulators, we found that individual pharmacologic inhibition of KDM1A and KDM5 by namoline and CPI-455 respectively, impairs androgen regulated transcription. Notably, combined inhibition of KDM1A and KDM5 downregulates AR expression in CRPC cells. Furthermore, combined KDM1A and KDM5 inhibition impairs PCa cell proliferation and invasion more than individual inhibition of KDM1A and KDM5B. Collectively our study has identified individual and cooperative mechanisms involving KDM1A and KDM5 in androgen signalling in PCa. Our findings support the further development of KDM1A and KDM5B inhibitors to treat advanced PCa. Further work is now required to confirm the therapeutic feasibility of combined inhibition of KDM1A and KDM5B as a novel therapeutic strategy for targeting AR positive CRPC.
first_indexed 2024-04-09T17:19:39Z
format Article
id doaj.art-a03a643cd6764996be2ac0f2c2df949e
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-09T17:19:39Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-a03a643cd6764996be2ac0f2c2df949e2023-04-19T05:19:24ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-04-011110.3389/fcell.2023.11164241116424The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancerVeronika M. Metzler0Simone de Brot1Daisy B. Haigh2Corinne L. Woodcock3Jennifer Lothion-Roy4Anna E. Harris5Emeli M. Nilsson6Atara Ntekim7Jenny L. Persson8Jenny L. Persson9Brian D. Robinson10Francesca Khani11Kristian B. Laursen12Lorraine J. Gudas13Michael S. Toss14Srinivasan Madhusudan15Emad Rakha16David M. Heery17Catrin S. Rutland18Nigel P. Mongan19Nigel P. Mongan20Jennie N. Jeyapalan21Biodiscovery Institute, University of Nottingham, Nottingham, United KingdomCOMPATH, Institute of Animal Pathology, University of Bern, Bern, SwitzerlandBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomDepartment of Oncology, University Hospital Ibadan, Ibadan, NigeriaDepartment of Molecular Biology, Umeå University, Umeå, SwedenDepartment of Biomedical Sciences, Malmö Universitet, Malmö, SwedenDepartment of Urology, Weill Cornell Medicine, New York, NY, United StatesDepartment of Urology, Weill Cornell Medicine, New York, NY, United StatesDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, United StatesDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, United StatesBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomSchool of Pharmacy, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, United StatesBiodiscovery Institute, University of Nottingham, Nottingham, United KingdomHistone H3 lysine 4 (H3K4) methylation is key epigenetic mark associated with active transcription and is a substrate for the KDM1A/LSD1 and KDM5B/JARID1B lysine demethylases. Increased expression of KDM1A and KDM5B is implicated in many cancer types, including prostate cancer (PCa). Both KDM1A and KDM5B interact with AR and promote androgen regulated gene expression. For this reason, there is great interested in the development of new therapies targeting KDM1A and KDM5B, particularly in the context of castrate resistant PCa (CRPC), where conventional androgen deprivation therapies and androgen receptor signalling inhibitors are no longer effective. As there is no curative therapy for CRPC, new approaches are urgently required to suppress androgen signalling that prevent, delay or reverse progression to the castrate resistant state. While the contribution of KDM1A to PCa is well established, the exact contribution of KDM5B to PCa is less well understood. However, there is evidence that KDM5B is implicated in numerous pro-oncogenic mechanisms in many different types of cancer, including the hypoxic response, immune evasion and PI3/AKT signalling. Here we elucidate the individual and cooperative functions of KDM1A and KDM5B in PCa. We show that KDM5B mRNA and protein expression is elevated in localised and advanced PCa. We show that the KDM5 inhibitor, CPI-455, impairs androgen regulated transcription and alternative splicing. Consistent with the established role of KDM1A and KDM5B as AR coregulators, we found that individual pharmacologic inhibition of KDM1A and KDM5 by namoline and CPI-455 respectively, impairs androgen regulated transcription. Notably, combined inhibition of KDM1A and KDM5 downregulates AR expression in CRPC cells. Furthermore, combined KDM1A and KDM5 inhibition impairs PCa cell proliferation and invasion more than individual inhibition of KDM1A and KDM5B. Collectively our study has identified individual and cooperative mechanisms involving KDM1A and KDM5 in androgen signalling in PCa. Our findings support the further development of KDM1A and KDM5B inhibitors to treat advanced PCa. Further work is now required to confirm the therapeutic feasibility of combined inhibition of KDM1A and KDM5B as a novel therapeutic strategy for targeting AR positive CRPC.https://www.frontiersin.org/articles/10.3389/fcell.2023.1116424/fullepigeneticssplicingtranscriptional regulationKDM-inhibitorshistone modification
spellingShingle Veronika M. Metzler
Simone de Brot
Daisy B. Haigh
Corinne L. Woodcock
Jennifer Lothion-Roy
Anna E. Harris
Emeli M. Nilsson
Atara Ntekim
Jenny L. Persson
Jenny L. Persson
Brian D. Robinson
Francesca Khani
Kristian B. Laursen
Lorraine J. Gudas
Michael S. Toss
Srinivasan Madhusudan
Emad Rakha
David M. Heery
Catrin S. Rutland
Nigel P. Mongan
Nigel P. Mongan
Jennie N. Jeyapalan
The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
Frontiers in Cell and Developmental Biology
epigenetics
splicing
transcriptional regulation
KDM-inhibitors
histone modification
title The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
title_full The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
title_fullStr The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
title_full_unstemmed The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
title_short The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
title_sort kdm5b and kdm1a lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
topic epigenetics
splicing
transcriptional regulation
KDM-inhibitors
histone modification
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1116424/full
work_keys_str_mv AT veronikammetzler thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT simonedebrot thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT daisybhaigh thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT corinnelwoodcock thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jenniferlothionroy thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT annaeharris thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT emelimnilsson thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT atarantekim thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennylpersson thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennylpersson thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT briandrobinson thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT francescakhani thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT kristianblaursen thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT lorrainejgudas thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT michaelstoss thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT srinivasanmadhusudan thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT emadrakha thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT davidmheery thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT catrinsrutland thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT nigelpmongan thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT nigelpmongan thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennienjeyapalan thekdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT veronikammetzler kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT simonedebrot kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT daisybhaigh kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT corinnelwoodcock kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jenniferlothionroy kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT annaeharris kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT emelimnilsson kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT atarantekim kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennylpersson kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennylpersson kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT briandrobinson kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT francescakhani kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT kristianblaursen kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT lorrainejgudas kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT michaelstoss kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT srinivasanmadhusudan kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT emadrakha kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT davidmheery kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT catrinsrutland kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT nigelpmongan kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT nigelpmongan kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer
AT jennienjeyapalan kdm5bandkdm1alysinedemethylasescooperateinregulatingandrogenreceptorexpressionandsignallinginprostatecancer